PRF1 and viral hepatitis: Using a novel pharmacological perforin-1 inhibitor, we demonstrate that blocking perforin-1 function rescues mice with viral hepatitis from fulminant liver failure, which may provide a salvage treatment strategy for patients with fulminant viral hepatitis.